Exacerbations of Severe Asthma in Patients Treated With Mepolizumab: Assessment of Biomarkers and Identification of Biologic Clusters
Latest Information Update: 07 May 2024
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Acronyms ESAM-BIO
- 21 Sep 2021 Status changed from not yet recruiting to recruiting.
- 11 Jun 2021 New trial record